Meeting
2023 ASCO Genitourinary Cancers Symposium
Factors related to men’s experience with prostate cancer germline testing.
Authors
Veda N. Giri
Yale School of Medicine and Yale Cancer Center, New Haven, CT
Veda N. Giri , Laura Gross , Rebecca Hartman , Amy Leader , Young E. Whang , Anna Couvillon , Heather H. Cheng , Channing Judith Paller , Stacy Loeb , Lawrence Ivan Karsh , Sue J. Friedman , Tomasz M. Beer , Alexandra Sokolova , Scott W. Keith
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 128)
DOI
10.1200/JCO.2023.41.6_suppl.128
Abstract #
128
Poster Bd #
D12
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Patient-reported outcomes among males undergoing prostate cancer germline testing: Interim results from the Prostate Cancer Genetic Risk, Experience, and Support Study (PROGRESS) Registry.
First Author: Veda N. Giri
Poster
2024 ASCO Breakthrough
Translating potential germline findings from tumour profiling into routine clinical care.
First Author: Milita Zaheed
Poster
2023 ASCO Genitourinary Cancers Symposium
Real world rates of genetic referrals and germline testing in patients with prostate adenocarcinoma at an academic cancer center in southern New Jersey.
First Author: Christopher Ambrogi
Poster
2021 Genitourinary Cancers Symposium
Barriers and facilitators of germline genetic evaluation for prostate cancer.
First Author: Stacy Loeb